It is the most frequent tumor. Annually about 417 thousand new cases / year are diagnosed in Europe. It represents the 3rd cause of death from cancer pathology.
1 in 7 European men will suffer from this disease.
The incidence has always been increasing for the past 20 years.
Currently, the suspicion arises with a high PSA value, however, the diagnosis is only confirmed with a positive biopsy for malignant cells - Prostate cancer is always asymptomatic, in the initial phase. (The presence of urinary symptoms may mean BPH ).
RANDOM TRANSRECTAL PROSTATIC BIOPSY
THE NEW PARADIGM
TRANSPERINEAL FUSION BIOPSY
• Multiparametric Magnetic Resonance (NMR) allows the location of the tumor (s) to be reliably located. When its result is normal, clinically significant Prostate Cancer is very unlikely (negative predictive value in the order of 95%).
• Transperineal fusion biopsy uses a matrix system with 5mm intervals, which allows not only an accurate three-dimensional location, but also a perfect classification. It is based on an augmented reality system in which the NMRmp image is superimposed on the ultrasound image in real time. Because it is not transrectal, the infection rate is virtually zero.
Note - Currently, many tumors are treated by adopting a focal strategy: breast, kidney, for example. The advantages of this approach relate to a much faster post-treatment recovery and practically zero side effects. Diagnostic technique is essential to accurately identify the focus to be treated.